Lonestar71
Member
I'm a 45YO white male. 6'1" 200#
Ordered Items
CBC With Differential/Platelet; Comp. Metabolic Panel (14); Lipid Panel w/ Chol/HDL Ratio; FSH and LH; Testosterone, Free+Total
LC/MS; Dihydrotestosterone; Thyroxine (T4) Free, Direct, S; DHEA-Sulfate; TSH; Prostate-Specific Ag, Serum; Estradiol, Sensitive;
Triiodothyronine,Free,Serum; Venipuncture
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
CBC With Differential/Platelet
WBC 9.5 x10E3/uL 3.4 - 10.8 01
RBC 4.72 x10E6/uL 4.14 - 5.80 01
Hemoglobin 15.7 g/dL 12.6 - 17.7 01
Hematocrit 45.0 % 37.5 - 51.0 01
MCV 95 fL 79 - 97 01
MCH 33.3 High pg 26.6 - 33.0 01
MCHC 34.9 g/dL 31.5 - 35.7 01
RDW 13.3 % 12.3 - 15.4 01
Platelets 260 x10E3/uL 150 - 379 01
Neutrophils 66 % 01
Lymphs 23 % 01
Monocytes 7 % 01
Eos 4 % 01
Basos 0 % 01
Neutrophils (Absolute) 6.3 x10E3/uL 1.4 - 7.0 01
Lymphs (Absolute) 2.2 x10E3/uL 0.7 - 3.1 01
Monocytes(Absolute) 0.7 x10E3/uL 0.1 - 0.9 01
Eos (Absolute) 0.3 x10E3/uL 0.0 - 0.4 01
Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01
Immature Granulocytes 0 % 01
Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01
Comp. Metabolic Panel (14)
Glucose, Serum 79 mg/dL 65 - 99 01
BUN 17 mg/dL 6 - 24 01
Creatinine, Serum 0.92 mg/dL 0.76 - 1.27 01
eGFR If NonAfricn Am 100 mL/min/1.73 >59
eGFR If Africn Am 116 mL/min/1.73 >59
Specimen ID: 013-363-0659-0
DOB: 12/18/1971 Date collected: 01/13/2017 0825 Local
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
BUN/Creatinine Ratio 18 9 - 20
Sodium, Serum 138 mmol/L 134 - 144 01
Potassium, Serum 4.5 mmol/L 3.5 - 5.2 01
Chloride, Serum 97 mmol/L 96 - 106 01
Carbon Dioxide, Total 21 mmol/L 18 - 29 01
Calcium, Serum 9.3 mg/dL 8.7 - 10.2 01
Protein, Total, Serum 6.9 g/dL 6.0 - 8.5 01
Albumin, Serum 4.4 g/dL 3.5 - 5.5 01
Globulin, Total 2.5 g/dL 1.5 - 4.5
A/G Ratio 1.8 1.1 - 2.5
Bilirubin, Total 0.6 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase, S 63 IU/L 39 - 117 01
AST (SGOT) 27 IU/L 0 - 40 01
ALT (SGPT) 29 IU/L 0 - 44 01
Lipid Panel w/ Chol/HDL Ratio
Cholesterol, Total 248 High mg/dL 100 - 199 01
Triglycerides 98 mg/dL 0 - 149 01
HDL Cholesterol 38 Low mg/dL >39 01
VLDL Cholesterol Cal 20 mg/dL 5 - 40
LDL Cholesterol Calc 190 High mg/dL 0 - 99
T. Chol/HDL Ratio 6.5 High ratio units 0.0 - 5.0
Please Note: 01
T. Chol/HDL Ratio
Men Women
1/2 Avg.Risk 3.4 3.3
Avg.Risk 5.0 4.4
2X Avg.Risk 9.6 7.1
3X Avg.Risk 23.4 11.0
FSH and LH
LH 6.6 mIU/mL 1.7 - 8.6 01
FSH 3.4 mIU/mL 1.5 - 12.4 01
Testosterone, Free+Total LC/MS
Testosterone, Total, LC/MS 318.7 Low ng/dL 348.0 - 1197.0 02
Adult male reference interval is based on a population of lean males
up to 40 years old.
Disclaimer: 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared or approved
by the Food and Drug Administration.
Free Testosterone(Direct) 11.1 pg/mL 6.8 - 21.5 02
Dihydrotestosterone 29 Low ng/dL 03
Reference Range:
All Rights Reserved - Enterprise Report Version:
qWERtyUi Patient Report
Specimen ID:
DOB: 12/18/1971 Date collected: 01/13/2017 0825 Local
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
Adult Male: 30 - 85
Thyroxine (T4) Free, Direct, S
T4,Free(Direct) 2.03 High ng/dL 0.82 - 1.77 01
DHEA-Sulfate 472.9 High ug/dL 71.6 - 375.4 01
TSH 1.030 uIU/mL 0.450 - 4.500 01
Prostate-Specific Ag, Serum
Prostate Specific Ag, Serum 0.4 ng/mL 0.0 - 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
Estradiol, Sensitive 12.3 pg/mL 8.0 - 35.0 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS)
Triiodothyronine,Free,Serum 3.5 pg/mL 2.0 - 4.4 01
Ordered Items
CBC With Differential/Platelet; Comp. Metabolic Panel (14); Lipid Panel w/ Chol/HDL Ratio; FSH and LH; Testosterone, Free+Total
LC/MS; Dihydrotestosterone; Thyroxine (T4) Free, Direct, S; DHEA-Sulfate; TSH; Prostate-Specific Ag, Serum; Estradiol, Sensitive;
Triiodothyronine,Free,Serum; Venipuncture
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
CBC With Differential/Platelet
WBC 9.5 x10E3/uL 3.4 - 10.8 01
RBC 4.72 x10E6/uL 4.14 - 5.80 01
Hemoglobin 15.7 g/dL 12.6 - 17.7 01
Hematocrit 45.0 % 37.5 - 51.0 01
MCV 95 fL 79 - 97 01
MCH 33.3 High pg 26.6 - 33.0 01
MCHC 34.9 g/dL 31.5 - 35.7 01
RDW 13.3 % 12.3 - 15.4 01
Platelets 260 x10E3/uL 150 - 379 01
Neutrophils 66 % 01
Lymphs 23 % 01
Monocytes 7 % 01
Eos 4 % 01
Basos 0 % 01
Neutrophils (Absolute) 6.3 x10E3/uL 1.4 - 7.0 01
Lymphs (Absolute) 2.2 x10E3/uL 0.7 - 3.1 01
Monocytes(Absolute) 0.7 x10E3/uL 0.1 - 0.9 01
Eos (Absolute) 0.3 x10E3/uL 0.0 - 0.4 01
Baso (Absolute) 0.0 x10E3/uL 0.0 - 0.2 01
Immature Granulocytes 0 % 01
Immature Grans (Abs) 0.0 x10E3/uL 0.0 - 0.1 01
Comp. Metabolic Panel (14)
Glucose, Serum 79 mg/dL 65 - 99 01
BUN 17 mg/dL 6 - 24 01
Creatinine, Serum 0.92 mg/dL 0.76 - 1.27 01
eGFR If NonAfricn Am 100 mL/min/1.73 >59
eGFR If Africn Am 116 mL/min/1.73 >59
Specimen ID: 013-363-0659-0
DOB: 12/18/1971 Date collected: 01/13/2017 0825 Local
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
BUN/Creatinine Ratio 18 9 - 20
Sodium, Serum 138 mmol/L 134 - 144 01
Potassium, Serum 4.5 mmol/L 3.5 - 5.2 01
Chloride, Serum 97 mmol/L 96 - 106 01
Carbon Dioxide, Total 21 mmol/L 18 - 29 01
Calcium, Serum 9.3 mg/dL 8.7 - 10.2 01
Protein, Total, Serum 6.9 g/dL 6.0 - 8.5 01
Albumin, Serum 4.4 g/dL 3.5 - 5.5 01
Globulin, Total 2.5 g/dL 1.5 - 4.5
A/G Ratio 1.8 1.1 - 2.5
Bilirubin, Total 0.6 mg/dL 0.0 - 1.2 01
Alkaline Phosphatase, S 63 IU/L 39 - 117 01
AST (SGOT) 27 IU/L 0 - 40 01
ALT (SGPT) 29 IU/L 0 - 44 01
Lipid Panel w/ Chol/HDL Ratio
Cholesterol, Total 248 High mg/dL 100 - 199 01
Triglycerides 98 mg/dL 0 - 149 01
HDL Cholesterol 38 Low mg/dL >39 01
VLDL Cholesterol Cal 20 mg/dL 5 - 40
LDL Cholesterol Calc 190 High mg/dL 0 - 99
T. Chol/HDL Ratio 6.5 High ratio units 0.0 - 5.0
Please Note: 01
T. Chol/HDL Ratio
Men Women
1/2 Avg.Risk 3.4 3.3
Avg.Risk 5.0 4.4
2X Avg.Risk 9.6 7.1
3X Avg.Risk 23.4 11.0
FSH and LH
LH 6.6 mIU/mL 1.7 - 8.6 01
FSH 3.4 mIU/mL 1.5 - 12.4 01
Testosterone, Free+Total LC/MS
Testosterone, Total, LC/MS 318.7 Low ng/dL 348.0 - 1197.0 02
Adult male reference interval is based on a population of lean males
up to 40 years old.
Disclaimer: 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared or approved
by the Food and Drug Administration.
Free Testosterone(Direct) 11.1 pg/mL 6.8 - 21.5 02
Dihydrotestosterone 29 Low ng/dL 03
Reference Range:
All Rights Reserved - Enterprise Report Version:
qWERtyUi Patient Report
Specimen ID:
DOB: 12/18/1971 Date collected: 01/13/2017 0825 Local
TESTS RESULT FLAG UNITS REFERENCE INTERVAL LAB
Adult Male: 30 - 85
Thyroxine (T4) Free, Direct, S
T4,Free(Direct) 2.03 High ng/dL 0.82 - 1.77 01
DHEA-Sulfate 472.9 High ug/dL 71.6 - 375.4 01
TSH 1.030 uIU/mL 0.450 - 4.500 01
Prostate-Specific Ag, Serum
Prostate Specific Ag, Serum 0.4 ng/mL 0.0 - 4.0 01
Roche ECLIA methodology.
According to the American Urological Association, Serum PSA should
decrease and remain at undetectable levels after radical
prostatectomy. The AUA defines biochemical recurrence as an initial
PSA value 0.2 ng/mL or greater followed by a subsequent confirmatory
PSA value 0.2 ng/mL or greater.
Values obtained with different assay methods or kits cannot be used
interchangeably. Results cannot be interpreted as absolute evidence
of the presence or absence of malignant disease.
Estradiol, Sensitive 12.3 pg/mL 8.0 - 35.0 02
This test was developed and its performance characteristics
determined by LabCorp. It has not been cleared by the Food and
Drug Administration.
Methodology: Liquid chromatography tandem mass spectrometry(LC/MS/MS)
Triiodothyronine,Free,Serum 3.5 pg/mL 2.0 - 4.4 01
Last edited by a moderator: